Back to company

ACUPHARMA ApS: Financial statements 2012

CVR: 10072956

ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 364,777 and a net result of DKK -227,134. Equity amounted to DKK 260,992. The solvency ratio was 16.8%.

Gross Profit
364,777 kr.
Profit/Loss
-227,134 kr.
Equity
260,992 kr.
Total Assets
1,555,036 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ACUPHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2012

ACUPHARMA ApS appoints new auditorSep 10, 2012

As of September 10, 2012, inforevision statsautoriseret revisionsaktieselskab has been appointed auditor of ACUPHARMA ApS.

Auditor steps down at ACUPHARMA ApSSep 10, 2012

As of September 10, 2012, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of ACUPHARMA ApS.

About ACUPHARMA ApS

ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees. In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity amounted to DKK -109,301.